For individuals suffering from treatment-resistant depression (TRD), finding effective relief can be challenging. SPRAVATO® (esketamine) offers new hope as a groundbreaking, FDA-approved therapy.

Delivered as a nasal spray in a controlled setting, SPRAVATO® works differently from traditional antidepressants, providing faster relief for those who haven’t responded to other treatments.

At Access Health Services in Lanham, MD, we offer SPRAVATO® therapy as part of our comprehensive approach to mental health care. Our team ensures a safe, supportive environment for patients seeking this innovative treatment, empowering them to reclaim their mental well-being.

SPRAVATO® is ideal for individuals who:

  • Have treatment-resistant depression and haven’t responded to at least two traditional antidepressants.
  • Struggle with major depressive disorder (MDD) accompanied by suicidal thoughts.
  • Require faster relief from depressive symptoms in crises.
  • Want an alternative therapy to enhance their existing mental health treatment.

Why Early Intervention with SPRAVATO® Matters?

Depression can severely impact everyday life, causing emotional distress, poor job performance, and strained relationships. Seeking timely treatment with SPRAVATO® can:

  • Alleviate depressive symptoms faster than standard medications.

  • Prevent further decline in mental health by addressing TRD directly.

  • Lower the risk of suicide by targeting acute depressive episodes.

  • Improve overall well-being making daily activities easier.

SPRAVATO® FAQ

SPRAVATO® works by targeting the NMDA receptor in the brain, providing faster symptom relief than traditional antidepressants, which can take weeks to be effective.

The duration and frequency will depend on your progress. Initial therapies are typically administered twice a week, gradually reducing over time as symptoms improve.

Common side effects include dizziness, nausea, and drowsiness. That’s why all SPRAVATO® sessions are supervised in a medical setting to ensure patient safety.

Many insurance plans cover psychological testing. Contact our office to verify your coverage.

No. Due to potential side effects like drowsiness, patients are prohibited from driving for 24 hours following their treatment session.

At Access Health Services, your SPRAVATO® treatment will occur in a supervised medical setting to ensure safety and comfort. Here’s what the process looks like:

  • Initial Assessment: A licensed mental health professional evaluates your medical history and current mental health status to confirm if SPRAVATO® is suitable.
  • First Treatment Session: SPRAVATO® is administered as a nasal spray under medical supervision, with monitoring for approximately two hours after administration.
  • Ongoing Sessions: Subsequent treatments follow a schedule based on your needs, typically starting with two sessions per week.
  • Continued Support: We monitor your progress closely to adjust your treatment plan as needed. You’ll have access to our compassionate team throughout your treatment, ensuring that you feel supported at every step of your journey.